Juckett, M.D., associate professor, in the division of neoplastic illnesses and related disorders; Amy A. Irving, B.A., study technologist in radiation oncology; John P. Klein, Ph.D., professor of human population director and health of biostatistics, and Julie-An M. Talano, M.D., assistant professor of pediatrics. The study was funded by the National Institutes of Health’s National Malignancy Institute, and by a grant from the American Cancer Culture.. Captopril might limit radiation kidney harm in bone marrow transplant sufferers Researchers in the Medical University of Wisconsin in Milwaukee have found that the chance of radiation injury in normal cells after exposure may be reduced by a drug in keeping use. Their study in press shows up in the online issue of the International Journal of Radiation Oncology, Biology and Physics.Employers should reject continuing to accomplish business with something that consistently raises in costs while slicing the level and number of solutions provided. Related StoriesCancer diagnosis improvements in England: an interview with Lucy Elliss-BrookesApplying a top restaurant model to healthcare communications: an interview with Brandi Robinson, SanofiDiabetic retinopathy therapy innovations: an interview with Richard Kirk, CEO of PolyphotonixClarion Treatment facilitates Company contributions into Worker Directed Accounts . Cunio explains, The worker after that uses their EDAs to manage their own health care including coverage and treatment options.